0001209191-16-111161.txt : 20160330 0001209191-16-111161.hdr.sgml : 20160330 20160330210048 ACCESSION NUMBER: 0001209191-16-111161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160328 FILED AS OF DATE: 20160330 DATE AS OF CHANGE: 20160330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blackburn Kelly CENTRAL INDEX KEY: 0001640575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 161541470 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-28 0 0001339970 aTYR PHARMA INC LIFE 0001640575 Blackburn Kelly 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO, CA CA 92121 0 1 0 0 VP, Clinical Affairs Restricted Stock Unit 2016-03-28 4 A 0 21600 0.00 A Common Stock 21600 21600 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 1/2 of the restricted stock units are scheduled to vest on March 28, 2017 and the remaining 1/2 are scheduled to vest on March 28, 2018. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. /s/ Nancy Krueger, as Power of Attorney 2016-03-30